Literature DB >> 34636809

Long-term HIV Pre-exposure Prophylaxis Trajectories Among Racial & Ethnic Minority Patients: Short, Declining, & Sustained Adherence.

Maria Pyra1,2, Russell Brewer2, Laura Rusie1, Jeanelle Kline1, India Willis1, John Schneider1,2.   

Abstract

BACKGROUND: HIV pre-exposure prophylaxis (PrEP) requires continued use at an effective dosage to reduce HIV incidence. Data suggest early PrEP drop-off among many populations. We sought to describe PrEP use over the first year among racial and ethnic minority patients in the US.
SETTING: Racial and ethnic minority patients initiating PrEP at a federally qualified health center in Chicago, IL.
METHODS: Using electronic health records, we determined the adherence (≥6 weekly doses) trajectories over the first year of PrEP use and compared baseline and time-varying patient characteristics.
RESULTS: From 2159 patients, we identified 3 PrEP use trajectories. Sustained use was the most common (40%) trajectory, followed by short use (30%) and declining use (29%). In adjusted models, younger age, Black race, as well as gender, sexual orientation, insurance status at baseline, and neighborhood were associated with trajectory assignment; within some trajectories, insurance status during follow-up was associated with odds of monthly adherence (≥6 weekly doses).
CONCLUSION: Among racial and ethnic minorities, a plurality achieved sustained PrEP persistence. Access to clinics, insurance, and intersectional stigmas may be modifiable barriers to effective PrEP persistence; in addition, focus on younger users and beyond gay, cismale populations are needed.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34636809      PMCID: PMC8752481          DOI: 10.1097/QAI.0000000000002833

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  42 in total

1.  Adherence to PrEP Among Young Men Who Have Sex With Men Participating in a Sexual Health Services Demonstration Project in Alameda County, California.

Authors:  Janet J Myers; Mi-Suk Kang Dufour; Kimberly A Koester; Ifeoma Udoh; Remi Frazier; Rebecca Packard; Kristin Kennedy; Xavier Erguera; Jessica Horowitz; Robert Grant; Jeffrey H Burack
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

2.  Patterns of PrEP Retention Among HIV Pre-exposure Prophylaxis Users in Baltimore City, Maryland.

Authors:  Linxuan Wu; Christina Schumacher; Aruna Chandran; Errol Fields; Ashley Price; Adena Greenbaum; Jacky M Jennings
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.731

3.  Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States.

Authors:  Sybil G Hosek; Raphael J Landovitz; Bill Kapogiannis; George K Siberry; Bret Rudy; Brandy Rutledge; Nancy Liu; D Robert Harris; Kathleen Mulligan; Gregory Zimet; Kenneth H Mayer; Peter Anderson; Jennifer J Kiser; Michelle Lally; Jennifer Brothers; Kelly Bojan; Jim Rooney; Craig M Wilson
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

4.  Preexposure prophylaxis care continuum among transgender women at a patient-centered preexposure prophylaxis program in Atlanta, Georgia.

Authors:  Amalia Aldredge; Grant Roth; Akanksha Vaidya; Ana Paula Duarte; Suprateek Kundu; Ziduo Zheng; Bradley L Smith; Meredith Lora; Judah Gruen; Anandi N Sheth; Jessica M Sales; Valeria D Cantos
Journal:  AIDS       Date:  2021-03-01       Impact factor: 4.177

5.  Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities.

Authors:  Philip A Chan; Leandro Mena; Rupa Patel; Catherine E Oldenburg; Laura Beauchamps; Amaya G Perez-Brumer; Sharon Parker; Kenneth H Mayer; Matthew J Mimiaga; Amy Nunn
Journal:  J Int AIDS Soc       Date:  2016-06-13       Impact factor: 5.396

6.  Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network.

Authors:  Matthew A Spinelli; Hyman M Scott; Eric Vittinghoff; Albert Y Liu; Rafael Gonzalez; Alicia Morehead-Gee; Monica Gandhi; Susan P Buchbinder
Journal:  Open Forum Infect Dis       Date:  2019-02-26       Impact factor: 3.835

7.  Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067.

Authors:  Sharon Mannheimer; Yael Hirsch-Moverman; Julie Franks; Avelino Loquere; James P Hughes; Maoji Li; K Rivet Amico; Robert M Grant
Journal:  J Acquir Immune Defic Syndr       Date:  2019-04-15       Impact factor: 3.731

8.  Global implementation of PrEP for HIV prevention: setting expectations for impact.

Authors:  Maria N Pyra; Jessica E Haberer; Nina Hasen; Jason Reed; Nelly R Mugo; Jared M Baeten
Journal:  J Int AIDS Soc       Date:  2019-08       Impact factor: 5.396

9.  HIV Pre-exposure Prophylaxis Use and Persistence among Black Ciswomen: "Women Need to Protect Themselves, Period".

Authors:  Maria Pyra; Amy K Johnson; Samantha Devlin; A Ziggy Uvin; Shemeka Irby; Eric Stewart; Cori Blum; Maya Green; Sadia Haider; Lisa R Hirschhorn; Jessica P Ridgway
Journal:  J Racial Ethn Health Disparities       Date:  2021-03-17

10.  Structural, Dosing, and Risk Change Factors Affecting Discontinuation of Pre-exposure Prophylaxis (PrEP) in a Large Urban Clinic.

Authors:  Chelsea L Shover; Michelle A DeVost; Nicole J Cunningham; Matthew R Beymer; David Flores; Risa Flynn; Pamina M Gorbach; Phoebe Lyman; K Rivet Amico; Robert K Bolan
Journal:  AIDS Educ Prev       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.